山东省人群血清尿酸变异性与冠心病发病风险的关系

doi:10.6040/j.issn.1671-7554.0.2020.1036

摘要/Abstract

摘要： 目的探讨山东省人群队列中血清尿酸变异性指标和冠心病发病风险之间的关系。方法依托山东省健康医疗大数据平台,构建30岁到80岁人群的冠心病发病队列。采用Cox比例风险模型研究不同血清尿酸变异性指标与冠心病发病风险的关系。变异性指标包括独立于均值的变异(VIM)、平均真实变异(ARV)和变异系数(CV)。结果在中位随访时间为8.50年的观察期间,新发冠心病患者1 931例,其中男1 420例,女511例,发病密度为10.60/千人年。在调整了年龄、性别、收缩压、空腹血糖、体质量指数、甘油三酯、高密度脂蛋白、低密度脂蛋白、平均血清尿酸水平和随访次数后,与血清尿酸变异性(VIM)的最低四分位组相比,第二到第四四分位组的HR分别为1.03(95%CI:0.90~1.19,P=0.674)、1.18(95%CI:1.03~1.35,P=0.018)和1.32(95%CI:1.16~1.51,P<0.001)。用ARV和CV表示变异所得到的结果与VIM类似。结论高水平的血清尿酸变异性是冠心病发病的风险因素。

关键词: 尿酸, 变异性, 冠心病, 独立于均值的变异, 平均真实变异, 变异系数

Abstract: Objective To explore the association between serum uric acid(SUA)variability and the risk of coronary heart disease(CHD)in Shandong Province. Methods Based on the Big Data Platform of Health Care in Shandong Province, the CHD incidence cohort of people aged 30 to 80 years was constructed. The association between CHD risk and variability independent of the mean(VIM), average real variability(ARV)and coefficient of variation(CV)was analyzed with Cox proportional hazards model. Results During the median follow-up of 8.50 years, 1 931 new CHD cases were diagnosed, including 1 420 males and 511 females, with an incidence density of 10.60/1000 person-year. After age, gender, systolic blood pressure, fasting plasma glucose, body mass index, triglycerides, high-density lipoprotein, low-density lipoprotein, average uric acid level and the number of follow-up were adjusted, HR for VIM were 1.03(95%CI: 0.90-1.19, P=0.674), 1.18(95%CI: 1.03-1.35, P=0.018)and 1.32(95%CI: 1.16-1.51, P<0.001)for quartiles 2 to 4, respectively. When ARV and CV were used for SUA variability, the results were similar to those of VIM. Conclusion High levels of SUA variability are risk factors of CHD.

Key words: Uric acid, Variability, Coronary heart disease, Variability independent of the mean, Average real variability, Coefficient of variation

中图分类号:

R181.2

刘聪聪,陈晓璐,司书成,王博洁,李云霞,李文超,袁同慧,薛付忠. 山东省人群血清尿酸变异性与冠心病发病风险的关系[J]. 山东大学学报 (医学版), 2020, 58(12): 109-116.

LIU Congcong, CHEN Xiaolu, SI Shucheng, WANG Bojie, LI Yunxia, LI Wenchao, YUAN Tonghui, XUE Fuzhong. Association between serum uric acid variability and risk of coronary heart disease in Shandong Province[J]. Journal of Shandong University (Health Sciences), 2020, 58(12): 109-116.

参考文献

[1] Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010 [J]. Lancet, 2013, 381(9882): 1987-2015.
[2] 胡盛寿, 高润霖, 刘力生, 等. 《中国心血管病报告2018》概要[J]. 中国循环杂志, 2019, 34(3): 209-220.
[3] Li X, Meng X, Timofeeva M, et al. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies [J]. BMJ, 2017, 357: 2376. doi: 10.1136/bmj.j2376.
[4] Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk [J]. N Engl J Med, 2008, 359(17): 1811-1821.
[5] Zuo T, Liu X, Jiang L, et al. Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies [J]. BMC Cardiovasc Disord, 2016, 16(1): 207.
[6] Lai X, Yang L, Legare S, et al. Dose-response relationship between serum uric acid levels and risk of incident coronary heart disease in the Dongfeng-Tongji Cohort [J]. Int J Cardiol, 2016, 224: 299-304. doi: 10.1016/j.ijcard.2016.09.035.
[7] Kim MK, Han K, Kim HS, et al. Effects of variability in blood pressure, glucose, and cholesterol concentrations, and body mass index on end-stage renal disease in the general population of Korea [J]. J Clin Med, 2019, 8(5): 755.
[8] Yoo JE, Shin DW, Han K, et al. Blood pressure variability and the risk of dementia: a nationwide cohort study [J]. Hypertension, 2020, 75(4): 982-990.
[9] Yang CP, Lin CC, Li CI, et al. Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes [J]. Cardiovasc Diabetol, 2020, 19(1): 4.
[10] Lim SS, Yang YL, Chen SC, et al. Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention [J]. Atherosclerosis, 2020, 297: 40-46. doi: 10.1016/j.atherosclerosis.2020.01.025.
[11] Kim JA, Kim J, Roh E, et al. Association of fasting plasma glucose variability with gestational diabetes mellitus: a nationwide population-based cohort study [J]. BMJ Open Diabetes Res Care, 2020, 8(1): e001084.
[12] Mena L, Pintos S, Queipo NV, et al. A reliable index for the prognostic significance of blood pressure variability [J]. J Hypertens, 2005, 23(3): 505-511.
[13] 周香, 施尚鹏, 曾力群, 等. 早发冠心病与晚发冠心病的危险因素及冠状动脉病变特点比较[J]. 中国循环杂志, 2017, 32(7): 638-641. ZHOU Xiang, SHI Shangpeng, ZENG Liqun, et al. Comparative study for risk factors and features in patients with premature coronary artery disease and mature coronary artery disease [J]. Chin Circul J, 2017, 32(7): 638-641.
[14] 高阅春, 何继强, 姜腾勇, 等. 冠心病患者冠状动脉病变严重程度与冠心病危险因素的相关分析[J]. 中国循环杂志, 2012, 27(3): 178-181. GAO Yuechun, HE Jiqiang, JIANG Tengyong, et al. Relationship of coronary stenosis severity with its risk factors in patients of coronary artery disease [J]. Chin Circul J, 2012, 27(3): 178-181.
[15] Grossman C, Grossman E, Goldbourt U. Uric acid variability at midlife as an independent predictor of coronary heart disease and all-cause mortality [J]. PLoS One, 2019, 14(8): e0220532.
[16] Li M, Hu X, Fan Y, et al. Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis [J]. Sci Rep, 2016, 6: 19520. doi: 10.1038/srep19520.
[17] Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? [J]. Hypertension, 2003, 41(6): 1183-1190.
[18] Bagnati M, Perugini C, Cau C, et al. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid [J]. Biochemical Journal, 1999, 340(1): 143-152.
[19] Battelli MG, Bortolotti M, Polito L, et al. The role of xanthine oxidoreductase and uric acid in metabolic syndrome [J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(8): 2557-2565.
[20] Yu MA, Sánchez-Lozada LG, Johnson RJ, et al. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction [J]. J Hypertens, 2010, 28(6): 1234-1242.
[21] Maruhashi T, Hisatome I, Kihara Y, et al. Hyperuricemia and endothelial function: From molecular background to clinical perspectives [J]. Atherosclerosis, 2018, 278: 226-231. doi: 10.1016/j.atherosclerosis.
[22] Ndrepepa G. Uric acid and cardiovascular disease [J]. Clin Chim Acta, 2018, 484: 150-163. doi: 10.1016/j.cca.2018.05.046.
[23] Hu L, Hu G, Xu BP, et al. U-Shaped association of serum uric acid with all-cause and cause-specific mortality in US adults: a cohort study [J]. J Clin Endocrinol Metab, 2020, 105(1): 68.
[24] Wang YF, Li JX, Sun XS, et al. High serum uric acid levels are a protective factor against unfavourable neurological functional outcome in patients with ischaemic stroke [J]. J Int Med Res, 2018, 46(5): 1826-1838.
[25] Wood AM, Kaptoge S, Butterworth AS, et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies[J]. Lancet, 2018, 391(10129): 1513-1523.
[26] Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes [J]. JAMA, 2013, 309(10): 1014-1021.

相关文章 15

[1]	张椿卉,王超艺,杨靖涵,张文霞,孔雨佳,石福艳,王素珍. 基于倾向性评分匹配法的体质量指数与高尿酸血症的关联性[J]. 山东大学学报 (医学版), 2026, 64(4): 100-108.
[2]	陈绪军,申林,陈军,于涛,曹广庆,肖飞. 解剖完全再血管化是冠心病外科治疗的新策略[J]. 山东大学学报 (医学版), 2025, 63(5): 12-17.
[3]	国科,陈绪军,郑宝石,黄克力,王晓武,陈景伟,林宇,罗俊辉,王海晨,王振东,廖成全,李有金,陈文生. 解剖完全再血管化全动脉冠脉旁路移植术多中心应用中期结果[J]. 山东大学学报 (医学版), 2025, 63(5): 18-25.
[4]	王刚,徐鹏演,赵旭安,王海锋,葛苗苗,潘华峰,江志伟. ω-3多不饱和脂肪酸对腹腔镜结直肠癌术后迷走神经和肠功能恢复的影响[J]. 山东大学学报 (医学版), 2025, 63(2): 36-42.
[5]	杨慧敏,龚万里,侯雅琪,吴静,王洋,贺培凤,于琦. 20种氨基酸与冠心病的因果关联:孟德尔随机化研究[J]. 山东大学学报 (医学版), 2025, 63(12): 6-16.
[6]	张恒哲,侯晓慧,Arezou Bikdeli,李大庆. 152例非急性心肌梗死患者完全血运重建介入治疗后疲劳程度的影响因素[J]. 山东大学学报 (医学版), 2023, 61(7): 47-54.
[7]	韩闯,程传龙,李春雨,刘盈,房启迪,崔峰,杨淑霞,韩鹏,李秀君. 气温日较差对淄博市冠心病入院人数的短期影响[J]. 山东大学学报 (医学版), 2023, 61(4): 111-118.
[8]	赵美茹,朱迪,刘淋,管庆波,张栩. 简易胰岛素抵抗指标与698例2型糖尿病患者发生高尿酸血症风险的关联[J]. 山东大学学报 (医学版), 2022, 60(12): 44-51.
[9]	谢佳莹,祁佳,宋铭,李育林,王迪,贾旭,张薇,钟明,尚嫄嫄. 血清蛋白质β-折叠水平与冠心病的相关性[J]. 山东大学学报 (医学版), 2022, 60(1): 21-26.
[10]	毛倩,王喆,管佩霞,刘玉洁,肖宇飞,杨毅,丛慧文,王廉源,石福艳,王素珍. 1 144例尿酸测值动态变化与痛风发病的关联性分析[J]. 山东大学学报 (医学版), 2021, 59(8): 107-112.
[11]	管帅,段世菲,夏晓娜,孟祥水,马祥兴. 双能光子CT对痛风诊断的应用价值[J]. 山东大学学报 (医学版), 2021, 59(2): 66-70.
[12]	李云霞,李洪凯,马韫韬,于媛媛,孙晓茹,刘新辉, 司书成,侯蕾,袁同慧,刘璐,李文超,薛付忠,刘言训. 基于两样本孟德尔随机化的身高和冠心病风险之间因果关系[J]. 山东大学学报 (医学版), 2020, 58(5): 107-114.
[13]	李明卓,孙秀彬,王春霞,杨洋,刘新辉,刘言训,薛付忠,袁中尚. 血脂正常人群HDL-C纵向变化与冠心病的关联性分析:一项回顾性队列研究[J]. 山东大学学报 (医学版), 2019, 57(8): 110-116.
[14]	林伟强,王春霞,李明卓,孙秀彬,刘言训,薛付忠,袁中尚. 中老年人血压变化轨迹与冠心病发病的关系[J]. 山东大学学报 (医学版), 2019, 57(4): 106-112.
[15]	刘新辉,李洪凯,李明卓,于媛媛,司书成,侯蕾,刘璐,李文超,袁同慧,李云霞,周宇畅,薛付忠. 腰围和冠心病因果关系的孟德尔随机化研究[J]. 山东大学学报 (医学版), 2019, 57(11): 103-109.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed